Depreciation, Depletion and Amortization in USD of HCW Biologics Inc. from 2020 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
HCW Biologics Inc. quarterly/annual Depreciation, Depletion and Amortization history and change rate from 2020 to Q1 2025.
- HCW Biologics Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2025 was $419K, a 72.1% increase year-over-year.
- HCW Biologics Inc. annual Depreciation, Depletion and Amortization for 2024 was $1.18M, a 4.34% increase from 2023.
- HCW Biologics Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.14M, a 58.1% increase from 2022.
- HCW Biologics Inc. annual Depreciation, Depletion and Amortization for 2022 was $718K, a 32.1% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)